Reccurent/Metastatic Solid Tumor Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Reccurent/Metastatic Solid Tumor Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingNot Applicable

NCT07483658

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20…

Study Overview This research compares two types of post-operative salvage radiotherapy (SRT) for men with prostate cancer who have had surgery but show signs of…

Canada434 participantsStarted 2026-02

Treatment: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radiotherapy (20 fractions)

CompletedPhase 2

NCT01771458

A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients…

SHIVA is a proof of concept randomized phase II trial which compares two treatment strategies for patients with refractory cancer. From a tumor biopsy, a molec…

France742 participantsStarted 2012-10

Treatment: Targeted therapy based on molecular profiling : Imatinib, Tumor biopsy